Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market Size Study by Product (Reagent, Instruments), Technology (Immunoassay, Molecular Diagnostics), End User (Research Institute, Hospital), and Regional Forecasts 2017-2025

    Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market Size Study by Product (Reagent, Instruments), Technology (Immunoassay, Molecular Diagnostics), End User (Research Institute, Hospital), and Regional Forecasts 2017-2025
    Date: 30 Nov, -0001
    Type:
    Pages: 80
    Geography: U.S. Canada UK Germany France China India Japan Brazil Mexico
    Code: 1000437
    Delivery Timeline:
    Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market to reach USD 5.1 billion by 2025.

    Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market valued approximately USD 2.1 billion in 2016 is anticipated to grow with a healthy growth rate of more than 10.3% over the forecast period 2017-2025. The increasing automation of high-throughput screening and the availability of robust data management software tools, which enable researchers to develop systemic and process-oriented approaches toward neuroscience antibodies and assays techniques are some of the factors contributing to the growth of this segment.

    The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

    By Product
    • Reagents
    • Instruments
    By Technology
    • Immunoassay
    • Molecular Diagnostics
    By End User
    • Research Institutes
    • Hospitals
    By Regions:
    • North America
    • U.S.
    • Canada
    • Europe
    • UK
    • Germany
    • Asia Pacific
    • China
    • India
    • Japan
    • Rest of the World

    Furthermore, years considered for the study are as follows:

    Historical year – 2015
    Base year – 2016
    Forecast period – 2017 to 2025

    Some of the key manufacturers involved in the market are. Thermo Fisher Scientific, Abcam, Bio-Rad, Merck KGAA, Cell Signaling Technology, Genscript, Rockland Immunochemicals. Bio Legend, Santa Cruz Biotechnology, Tecan, F. Hoffmann-La Roche, Siemens. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

    Target Audience of the Global NEUROSCIENCE ANTIBODIES AND ASSAYS in Market Study:

    • Key Consulting Companies & Advisors
    • Large, medium-sized, and small enterprises
    • Venture capitalists
    • Value-Added Resellers (VARs)
    • Third-party knowledge providers
    • Investment bankers
    • Investors
    TABLE OF CONTENTS
    Chapter 1. Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market Definition and Scope
    1.1. Research Objective
    1.2. Market Definition
    1.3. Scope of The Study
    1.4. Years Considered for The Study
    1.5. Currency Conversion Rates
    1.6. Report Limitation
    Chapter 2. Research Methodology
    2.1. Research Process
    2.1.1. Data Mining
    2.1.2. Analysis
    2.1.3. Market Estimation
    2.1.4. Validation
    2.1.5. Publishing
    2.2. Research Assumption
    Chapter 3. Executive Summary
    3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
    3.2. Key Trends
    Chapter 4. Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market Dynamics
    4.1. Growth Prospects
    4.1.1. Drivers
    4.1.2. Restraints
    4.1.3. Opportunities
    4.2. Industry Analysis
    4.2.1. Porter’s 5 Force Model
    4.2.2. PEST Analysis
    4.2.3. Value Chain Analysis
    4.3. Analyst Recommendation & Conclusion

    Chapter 5. Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market, By Product
    5.1. Market Snapshot
    5.2. Market Performance - Potential Model
    5.3. Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market, Sub Segment Analysis
    5.3.1. Reagents

    5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    5.3.2. Instruments

    5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    Chapter 6. Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market, by Application
    6.1. Market Snapshot
    6.2. Market Performance - Potential Model
    6.3. Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market, Sub Segment Analysis

    6.3.1. Immunoassay

    6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    6.3.2. Molecular Diagnostics

    6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    Chapter 7. Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market, by End-User
    7.1. Market Snapshot
    7.2. Market Performance - Potential Model
    7.3. Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market, Sub Segment Analysis

    7.1.1. Research Institutes

    7.1.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.1.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.1.2. Hospitals

    7.1.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.1.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    Chapter 8. Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market, by Regional Analysis
    8.1. NEUROSCIENCE ANTIBODIES AND ASSAYS Market, Regional Market Snapshot (2015-2025)
    8.2. North America NEUROSCIENCE ANTIBODIES AND ASSAYS Market Snapshot
    8.2.1. U.S.
    8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2. Canada
    8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3. Europe NEUROSCIENCE ANTIBODIES AND ASSAYS Market Snapshot
    8.3.1. U.K.
    8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2. Germany
    8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3. France
    8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4. Rest of Europe
    8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4. Asia NEUROSCIENCE ANTIBODIES AND ASSAYS Market Snapshot
    8.4.1. China
    8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2. India
    8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3. Japan
    8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4. Rest of Asia Pacific
    8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5. Rest of The World
    8.5.1. South America
    8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2. Middle East and Africa
    8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.4. End-User breakdown estimates & forecasts, 2015-2025 (USD Billion)
    Chapter 9. Competitive Intelligence
    9.1. Company Market Share (Subject to Data Availability)
    9.2. Top Market Strategies
    9.3. Company Profiles
    9.3.1. Thermo Fisher Scientific Inc.

    9.3.1.1. Overview
    9.3.1.2. Financial (Subject to Data Availability)
    9.3.1.3. Product Summary
    9.3.1.4. Recent Developments



    9.3.2. Abcam
    9.3.3. Bio-Rad
    9.3.4. Merck KGaA
    9.3.5. Cell Signaling Technology
    9.3.6. Genscript
    9.3.7. Rockland Immunochemicals
    9.3.8. BioLegend
    9.3.9. Santa Cruz Biotechnology
    9.3.10. Tecan
    9.3.11. F. Hoffmann-La Roche
    9.3.12. Siemens
    TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET
    TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET
    TABLE 3. BATTERY MATERIAL MARKET, REPORT SCOPE
    TABLE 4. YEARS CONSIDERED FOR THE STUDY
    TABLE 5. EXCHANGE RATES CONSIDERED
    TABLE 6. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
    TABLE 7. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION)
    TABLE 8. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)
    TABLE 9. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 10. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 11. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 12. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 13. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 14. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 15. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 16. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 17. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 18. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 19. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 20. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 21. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 22. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 23. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 24. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 25. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 26. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 27. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 28. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 29. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 30. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 31. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 32. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 33. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 34. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 35. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 36. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 37. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 38. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 39. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 40. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 41. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 42. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 43. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 44. GLOBAL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 45. U.S. NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 46. U.S. NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 47. U.S. NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 48. U.S. NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 49. U.S. NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 50. CANADA NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 51. CANADA NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 52. CANADA NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 53. CANADA NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 54. CANADA NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 55. UK NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 56. UK NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 57. UK NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 58. UK NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 59. UK NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 60. GERMANY NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 61. GERMANY NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 62. GERMANY NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 63. GERMANY NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 64. GERMANY NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 65. ROE NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 66. ROE NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 67. ROE NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 68. ROE NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 69. ROE NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 70. CHINA NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 71. CHINA NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 72. CHINA NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 73. CHINA NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 74. CHINA NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 75. INDIA NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 76. INDIA NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 77. INDIA NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 78. INDIA NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 79. INDIA NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 80. JAPAN NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 81. JAPAN NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 82. JAPAN NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 83. JAPAN NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 84. JAPAN NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 85. ROAPAC NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 86. ROAPAC NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 87. ROAPAC NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 88. ROAPAC NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 89. ROAPAC NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 90. BRAZIL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 91. BRAZIL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 92. BRAZIL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 93. BRAZIL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 94. BRAZIL NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 95. MEXICO NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 96. MEXICO NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 97. MEXICO NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 98. MEXICO NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 99. MEXICO NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 100. ROLA NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 101. ROLA NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 102. ROLA NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 103. ROLA NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 104. ROLA NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 105. ROW NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
    TABLE 106. ROW NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 107. ROW NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 108. ROW NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    TABLE 109. ROW NEUROSCIENCE ANTIBODIES AND ASSAYS MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
    FIG 1. GLOBAL A2P SMS MARKET, RESEARCH METHODOLOGY
    FIG 2. GLOBAL A2P SMS MARKET, MARKET ESTIMATION TECHNIQUES
    FIG 3. MARKET SIZE ESTIMATES & FORECAST METHODS
    FIG 4. GLOBAL A2P SMS MARKET, KEY TRENDS 2016
    FIG 5. GLOBAL A2P SMS MARKET, GROWTH PROSPECTS 2017-2025
    FIG 6. GLOBAL A2P SMS MARKET, PORTERS 5 FORCE MODEL
    FIG 7. GLOBAL A2P SMS MARKET, PEST ANALYSIS
    FIG 8. GLOBAL A2P SMS MARKET, VALUE CHAIN ANALYSIS
    FIG 9. GLOBAL A2P SMS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 10. GLOBAL A2P SMS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 11. GLOBAL A2P SMS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 12. GLOBAL A2P SMS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 13. GLOBAL A2P SMS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 14. GLOBAL A2P SMS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 15. GLOBAL A2P SMS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 16. GLOBAL A2P SMS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 17. GLOBAL A2P SMS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 18. GLOBAL A2P SMS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 19. GLOBAL A2P SMS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 20. GLOBAL A2P SMS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 21. GLOBAL A2P SMS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 22. GLOBAL A2P SMS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 23. GLOBAL A2P SMS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 24. GLOBAL A2P SMS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 25. GLOBAL A2P SMS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 26. GLOBAL A2P SMS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 27. GLOBAL A2P SMS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 28. GLOBAL A2P SMS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 29. GLOBAL A2P SMS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 30. GLOBAL A2P SMS MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
    FIG 31. GLOBAL A2P SMS MARKET, REGIONAL SNAPSHOT 2015 & 2025
    FIG 32. NORTH AMERICA A2P SMS MARKET 2015 & 2025 (USD BILLON)
    FIG 33. EUROPE A2P SMS MARKET 2015 & 2025 (USD BILLON)
    FIG 34. ASIA PACIFIC A2P SMS MARKET 2015 & 2025 (USD BILLON)
    FIG 35. LATIN AMERICA A2P SMS MARKET 2015 & 2025 (USD BILLON)
    FIG 36. A2P SMS MARKET, COMPANY MARKET SHARE ANALYSIS (2016)
    Thermo Fisher Scientific Inc.



    Overview

    Financial (Subject to Data Availability)

    Product Summary

    Recent Developments







    Abcam

    Bio-Rad

    Merck KGaA

    Cell Signaling Technology

    Genscript

    Rockland Immunochemicals

    BioLegend

    Santa Cruz Biotechnology

    Tecan

    F. Hoffmann-La Roche

    Siemens
    • Single User License
      $3,950.00
    • Enterprise Site License
      $5,550.00

    Why Us?

    Diligent Market mission is to provide "insight across the value chain" to help organizations make important business decisions through the use and analysis of actionable market intelligence. It is our mission to provide the most effective results and services coupled with acute client care to create a long-lasting relationship with our clients.